Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
US Department of Justice
Daiichi Sankyo

Generated: December 18, 2017

DrugPatentWatch Database Preview

Pilocarpine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for pilocarpine hydrochloride and what is the scope of pilocarpine hydrochloride freedom to operate?

Pilocarpine hydrochloride
is the generic ingredient in four branded drugs marketed by Alcon, Novartis Pharms Corp, Akorn Inc, Impax Labs, Innogenix, Lannett, Perrigo Pharma Intl, and Eisai Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for pilocarpine hydrochloride. Thirteen suppliers are listed for this compound.

Pharmacology for pilocarpine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
InnogenixPILOCARPINE HYDROCHLORIDEpilocarpine hydrochlorideTABLET;ORAL076963-001Dec 22, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpISOPTO CARPINEpilocarpine hydrochlorideSOLUTION;OPHTHALMIC200890-002Jun 22, 2010ATRXYesNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpISOPTO CARPINEpilocarpine hydrochlorideSOLUTION;OPHTHALMIC200890-003Jun 22, 2010ATRXYesYes► Subscribe► Subscribe► Subscribe
Eisai IncSALAGENpilocarpine hydrochlorideTABLET;ORAL020237-001Mar 22, 1994ABRXYesNo► Subscribe► Subscribe► Subscribe
Eisai IncSALAGENpilocarpine hydrochlorideTABLET;ORAL020237-002Apr 18, 2003ABRXYesYes► Subscribe► Subscribe► Subscribe
InnogenixPILOCARPINE HYDROCHLORIDEpilocarpine hydrochlorideTABLET;ORAL076963-002Feb 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
LannettPILOCARPINE HYDROCHLORIDEpilocarpine hydrochlorideTABLET;ORAL077220-001Oct 14, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax LabsPILOCARPINE HYDROCHLORIDEpilocarpine hydrochlorideTABLET;ORAL077248-002Mar 31, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn IncPILOCARPINE HYDROCHLORIDEpilocarpine hydrochlorideSOLUTION;OPHTHALMIC204398-002Sep 27, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpISOPTO CARPINEpilocarpine hydrochlorideSOLUTION;OPHTHALMIC200890-001Jun 22, 2010ATRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: